Live feed
Filing
SC 13G/A
SC 13G/A0001214659-23-009576·ASLAN Pharmaceuticals Ltd
Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 04522R200
Event date: 2023-07-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-23-009576
- Form type
- SC 13G/A
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Jul 13, 2023
- Reporting period
- Jul 11, 2023
- Description
- Schedule 13G beneficial ownership